Toward an integrated map of genetic interactions in cancer cells

Area of Science:

• Genomics
• Cancer Biology
• Computational Biology

Background:

• Cancer genomes accumulate numerous molecular aberrations, driving tumorigenesis and creating therapeutic vulnerabilities.
• Identifying genotype-dependent vulnerabilities is crucial for targeted cancer therapies.
• Previous methods for genetic network discovery were limited in scope and scalability.

Purpose of the Study:

• To develop a computational framework (MINGLE) for integrating diverse CRISPR/Cas9 screening data.
• To identify novel genotype-specific vulnerabilities in human cancer cells.
• To construct the largest comprehensive genetic interaction network in cancer.

Main Methods:

• Developed MINGLE, a framework integrating data from multiple CRISPR/Cas9 libraries.
• Applied MINGLE to analyze 85 CRISPR/Cas9 screens in human cancer cells.
• Integrated functional screening data with genetic variant information to explore gene-background relationships.

Main Results:

• Integrated over 2.1 million gene-background relationships from 85 CRISPR/Cas9 screens.
• Identified novel genotype-specific vulnerabilities in cancer cells beyond known dependencies.
• Validated GANAB and PRKCSH as new positive regulators of Wnt/β-catenin signaling.
• Constructed the largest genetic network in cancer cells to date by clustering genes with similar profiles.

Conclusions:

• MINGLE provides a scalable approach to integrate diverse genetic screens for systematic discovery.
• This framework enables the dynamic expansion of informative genetic interaction maps in cancer.
• The identified vulnerabilities and genetic network offer new avenues for therapeutic exploitation in cancer treatment.